chr3-17089910-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The NM_001144382.2(PLCL2):āc.3382T>Gā(p.Ter1128GlyextTer5) variant causes a stop lost change. The variant allele was found at a frequency of 0.00141 in 1,611,642 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0073 ( 16 hom., cov: 33)
Exomes š: 0.00079 ( 15 hom. )
Consequence
PLCL2
NM_001144382.2 stop_lost
NM_001144382.2 stop_lost
Scores
1
2
4
Clinical Significance
Conservation
PhyloP100: 4.31
Genes affected
PLCL2 (HGNC:9064): (phospholipase C like 2) Enables GABA receptor binding activity. Predicted to be involved in negative regulation of cold-induced thermogenesis and phosphatidylinositol-mediated signaling. Predicted to act upstream of or within several processes, including B cell activation; gamma-aminobutyric acid signaling pathway; and negative regulation of B cell receptor signaling pathway. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
Stoplost variant in NM_001144382.2 Downstream stopcodon found after 1155 codons.
BP6
Variant 3-17089910-T-G is Benign according to our data. Variant chr3-17089910-T-G is described in ClinVar as [Benign]. Clinvar id is 767888.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00728 (1109/152300) while in subpopulation AFR AF= 0.0249 (1034/41570). AF 95% confidence interval is 0.0236. There are 16 homozygotes in gnomad4. There are 505 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1109 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLCL2 | NM_001144382.2 | c.3382T>G | p.Ter1128GlyextTer5 | stop_lost | 6/6 | ENST00000615277.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLCL2 | ENST00000615277.5 | c.3382T>G | p.Ter1128GlyextTer5 | stop_lost | 6/6 | 1 | NM_001144382.2 | ||
PLCL2 | ENST00000432376.5 | c.3004T>G | p.Ter1002GlyextTer5 | stop_lost | 6/6 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00725 AC: 1104AN: 152182Hom.: 16 Cov.: 33
GnomAD3 genomes
AF:
AC:
1104
AN:
152182
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00205 AC: 509AN: 248252Hom.: 5 AF XY: 0.00152 AC XY: 204AN XY: 134152
GnomAD3 exomes
AF:
AC:
509
AN:
248252
Hom.:
AF XY:
AC XY:
204
AN XY:
134152
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000794 AC: 1159AN: 1459342Hom.: 15 Cov.: 31 AF XY: 0.000690 AC XY: 501AN XY: 725990
GnomAD4 exome
AF:
AC:
1159
AN:
1459342
Hom.:
Cov.:
31
AF XY:
AC XY:
501
AN XY:
725990
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00728 AC: 1109AN: 152300Hom.: 16 Cov.: 33 AF XY: 0.00678 AC XY: 505AN XY: 74452
GnomAD4 genome
AF:
AC:
1109
AN:
152300
Hom.:
Cov.:
33
AF XY:
AC XY:
505
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
100
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
300
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 23, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
N;N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at